Health · Medical Research · 15 hrs ago

Early trial finds ERAS-0015 safe and shrinks some lung and pancreatic tumors

Early trial finds ERAS-0015 safe and shrinks some lung and pancreatic tumors

The AURORAS-1 Phase I trial tested ERAS-0015, an anticancer drug, in people with cancer.

The study focused on hard-to-treat diseases, including lung and pancreatic cancer.

Results showed that the drug was safe in the trial.

It also caused some tumors to shrink in patients.

These findings are an early result from a Phase I study, rather than evidence that the drug cures these cancers.

The results may matter because both cancers can be difficult to treat.

The source gives no details about next steps for the drug or trial.

1 source

Related